| TAP |
Report |
Net Sales (Q2 2026) |
MISS |
pred ~$3.05B vs cons $3.093B |
MEDIUM |
| TAP |
Report |
Diluted EPS Operating (Q2 2026) |
BEAT |
pred ~$1.62 vs cons $1.525 |
MEDIUM |
| TAP |
Guide |
FY2026 EPS (FY period) |
UNCHANGED |
guide mid ~$4.72 vs cons $4.722 |
MEDIUM |
| TAP |
Guide |
FY2026 Net Sales (FY period) |
UNCHANGED |
guide flat +/-1% vs cons $11.106B (within range) |
MEDIUM |
| TAP |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| TAP |
Return |
5-day cumulative residual |
-2.5% (FADE) |
FADE — sell-side H2 estimate cuts follow FY reaffirm math; short covering provides partial offset but insufficient to reverse |
MEDIUM |